浙江三美化工股份有限公司监事会 （以下无正文） （本页无正文，为《浙江三美化工股份有限公司监事会关于公司 2025 年员工持 股计划相关事项的核查意见》之签字页） 关于 2025 年员工持股计划相关事项的核查意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国 证券法》（以下简称"《证券法》"）、《上海证券交易所股票上市规则》和《浙江三 美化工股份有限公司章程》（以下简称"《公司章程》"）等有关规定，浙江三美化 工股份有限公司（以下简称"公司"）监事会对公司 2025 年员工持股计划（以下 简称"本次员工持股计划"）相关事项发表意见如下： 1、本次员工持股计划方案符合《公司法》《证券法》《关于上市公司实施员 工持股计划试点的指导意见》（以下简称"《指导意见》"）、《上海证券交易所上市 公司自律监管指引第 1 号——规范运作》等相关法律法规和《公司章程》的规定， 审议程序符合规定，不存在损害公司及股东利益的情形。 2、未发现公司存在《指导意见》等法律法规规定的禁止实施员工持股计划 的情形。 3、本次员工持股计划遵循依法合规、自愿参与、风险自担的原则，公司不 存在以摊派、强行分配等方式强 ...

证券代码：603379 证券简称：三美股份 公告编号：2025- 005 一、审议通过《关于<浙江三美化工股份有限公司 2025 年员工持股计划（草 案）>及摘要的议案》。 为配合公司中长期发展战略规划，建立和完善员工、股东的利益共享机制， 公司拟实施 2025 年员工持股计划（以下简称"本次员工持股计划"）。具体详 见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《浙江三美化工股 份有限公司 2025 年员工持股计划（草案）》及《浙江三美化工股份有限公司 2025 年员工持股计划（草案）摘要》。 表决结果：4 票同意，0 票反对，0 票弃权，5 票回避。关联董事占林喜、吴 韶明、胡有团、徐能武、王富强对本议案回避表决。 浙江三美化工股份有限公司 第六届董事会第十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三美化工股份有限公司（以下简称"公司"）于 2025 年 2 月 9 日以现 场结合通讯方式召开第六届董事会第十六次会议。会议通知已于 2025 年 2 月 5 日以书面、电子邮 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for future performance [10]. Core Views - The company is expected to achieve a significant year-on-year increase in performance, driven by the sustained demand and price increases in refrigerants [5][6]. - The forecast for 2024 indicates a projected net profit attributable to shareholders of between 7.02 billion to 8.14 billion yuan, representing a year-on-year growth of 150.87% to 191.01% [4][5]. - The company is actively expanding its fluorochemical industry chain, which is expected to enhance its product structure and profitability [7]. Summary by Sections Financial Performance - The company anticipates a net profit of 7.02 to 8.14 billion yuan for 2024, with a substantial increase in the average market prices of its main refrigerant products [5]. - The projected net profit for 2025 is expected to continue the upward trend, benefiting from ongoing price increases in refrigerants [6]. Market Dynamics - The report highlights that the refrigerant market is experiencing a favorable cycle, with supply constraints and robust downstream demand contributing to price increases [6]. - The average market prices for key refrigerants such as R32, R125, R134a, and R22 are projected to rise significantly, with year-on-year increases of 122%, 47%, 37%, and 42% respectively [5]. Strategic Initiatives - The company is leveraging its resource advantages to expand its fluorochemical product offerings, including several new projects aimed at enhancing production capacity [7]. - Projects include the production of lithium bis(fluorosulfonyl)imide and various fluoropolymer products, which are expected to contribute to future profitability [7].

Investment Rating - The investment rating for the company is "Recommended (Maintain)" with a current price of 42.92 CNY [1]. Core Views - The company is expected to achieve a net profit attributable to shareholders of 702 million to 814 million CNY in 2024, representing a year-on-year increase of 150.87% to 191.01% [4][8]. - The supply-demand structure for refrigerants is improving, with prices expected to continue rising, benefiting the company's performance [8][9]. Summary by Relevant Sections Company Overview - The company operates in the basic chemical industry and is a leading domestic refrigerant manufacturer [1]. - Major shareholder is Hu Rongda, holding 37.83% of shares [1]. Financial Performance - Revenue for 2024 is projected at 4.171 billion CNY, a year-on-year increase of 25.1% [6]. - The net profit for 2024 is expected to be 715 million CNY, a significant recovery from 280 million CNY in 2023 [6]. - The gross margin is anticipated to improve to 23.8% in 2024 from 13.4% in 2023 [6]. Market Dynamics - The implementation of quota systems for refrigerants in 2024 is expected to tighten supply, with the company holding a 15.7% share of the total production quota for third-generation refrigerants [8]. - The demand for refrigerants is projected to rise due to policies promoting the replacement of old appliances and strong export performance in the air conditioning sector [8]. Future Outlook - For 2025, the company is expected to maintain its leading position in the refrigerant market, with a projected net profit of 791 million CNY [9]. - The anticipated increase in production quotas for third-generation refrigerants and supportive government policies are expected to drive demand and stabilize prices [9].

Investment Rating - The investment rating for Sanmei Co., Ltd. is "Buy" (maintained) [1][11]. Core Views - The company is expected to achieve a significant year-on-year profit increase in 2024, with a projected net profit of 7.02 to 8.14 billion yuan, representing a growth of 150.87% to 191.01% [5]. - The refrigerant market is anticipated to continue its upward trend, leading to a potential "double-up" main rising market for the company in 2025 [6]. - The company has adjusted its profit forecasts for 2024 to 2026, with expected net profits of 7.72 billion, 18.07 billion, and 23.00 billion yuan respectively [5]. Financial Summary - The company’s revenue is projected to increase from 4.117 billion yuan in 2024 to 5.594 billion yuan in 2025, reflecting a year-on-year growth of 35.9% [8]. - The gross profit margin is expected to rise significantly from 30.7% in 2024 to 47.7% in 2025, indicating improved profitability [8]. - The earnings per share (EPS) is forecasted to increase from 1.26 yuan in 2024 to 2.96 yuan in 2025 [8]. Market Dynamics - Recent price increases in key refrigerants such as R32 and R134a are expected to benefit the company, with prices rising by 33% and 34% respectively compared to their 2024 average [6]. - The company’s total quota for major refrigerants in 2025 is approximately 12.90 million tons, positioning it well to capitalize on the rising market [6]. Valuation Metrics - The current price-to-earnings (P/E) ratio is 34.0 for 2024, decreasing to 14.5 for 2025, indicating a more attractive valuation as earnings grow [8]. - The price-to-book (P/B) ratio is projected to decline from 4.0 in 2024 to 3.2 in 2025, suggesting improved valuation metrics as the company’s financial performance strengthens [8].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1] Core Views - The company is expected to achieve a net profit attributable to shareholders of 700 million to 810 million yuan in 2024, representing a year-on-year growth of 151% to 191% [2][4] - The company is entering the quota year for the third-generation refrigerants, with supply constraints leading to price increases and improved profitability for its products [2][4] - The long-term outlook for the refrigerant industry remains positive due to structural reforms and increasing demand, particularly in the air conditioning sector [3][4] Summary by Relevant Sections Financial Performance - The projected net profit for 2024 is between 700 million and 810 million yuan, with a growth rate of 150.9% to 191.0% year-on-year. The non-recurring net profit is expected to be between 670 million and 780 million yuan, with a growth of 221.3% to 274.9% [2][4] - For the fourth quarter of 2024, the estimated net profit is between 139 million and 249 million yuan [2][4] Market Dynamics - The third-generation refrigerants are entering a quota year, which is expected to tighten supply and increase prices. The prices of mainstream refrigerants have been rising significantly, with R22, R32, R134a, and R143a showing substantial year-on-year increases [3][9] - As of January 20, 2025, the prices for R22, R32, R134a, and R143a have increased by 74%, 121%, 52%, and -8% respectively compared to the same period in 2024 [9][14] Future Outlook - The company is expected to benefit from the ongoing price increases in refrigerants and plans to expand into new materials and renewable energy sectors [3][15] - Revenue forecasts for 2024, 2025, and 2026 are adjusted to 44.08 billion, 55.02 billion, and 57.96 billion yuan respectively, with net profits of 7.88 billion, 11.38 billion, and 13.35 billion yuan [3][15]

Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Insights - The company is expected to achieve a net profit attributable to shareholders of 7.02 to 8.14 billion yuan in 2024, representing a year-on-year growth of 151% to 191% [7] - The refrigerant prices are expected to continue rising, supported by both domestic and international trade, indicating a favorable industry outlook [7] - The company is investing in new projects to enhance its integrated industrial chain in the fluorochemical sector, which is expected to improve its market position [7] Financial Data and Earnings Forecast - Total revenue is projected to increase from 3,334 million yuan in 2023 to 5,087 million yuan in 2025, with a compound annual growth rate of approximately 30% [6] - The net profit attributable to shareholders is forecasted to rise from 280 million yuan in 2023 to 1,315 million yuan in 2025, reflecting a significant growth trajectory [6] - The company's earnings per share (EPS) is expected to grow from 0.46 yuan in 2023 to 2.15 yuan in 2025 [6]

Financial Performance Forecast - The company expects a net profit attributable to shareholders for 2024 to be between 701.56 million and 813.81 million CNY, representing an increase of 421.91 million to 534.16 million CNY compared to the previous year, with a year-on-year growth of 150.87% to 191.01%[2] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses for 2024 is projected to be between 672.20 million and 784.45 million CNY, an increase of 462.97 million to 575.21 million CNY compared to the previous year, with a year-on-year growth of 221.27% to 274.92%[3] - In 2023, the company achieved a net profit attributable to shareholders of 279.64 million CNY and a net profit of 209.23 million CNY after deducting non-recurring gains and losses[5] Profit Drivers - The increase in profit is primarily attributed to the rise in prices of hydrofluorocarbon (HFCs) refrigerants due to quota management implemented in 2024, enhancing product profitability[6] Non-Recurring Gains and Losses - The company anticipates non-recurring gains and losses for 2024 to amount to 29.36 million CNY, which is a decrease of 41.05 million CNY compared to the previous year[6] Forecast Reliability - The earnings forecast is based on preliminary estimates and has not been audited by an accounting firm, with no significant uncertainties affecting the accuracy of the forecast[7]

证券代码：603379 证券简称：三美股份 公告编号：2025-001 浙江三美化工股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 1 月 2 日 内容详见 2025 年 1 月 2 日公司在上海证券交易所网站 www.sse.com.cn 以及 2025 年 1 月 3 日在《上海证券报》披露的《浙江三美化工股份有限公司关于使 用闲置自有资金委托理财的公告》。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 特此公告 第六届董事会第十五次会议决议公告 浙江三美化工股份有限公司董事会 浙江三美化工股份有限公司（以下简称"公司"）于 2024 年 12 月 31 日以现 场结合通讯表决方式在公司会议室召开第六届董事会第十五次会议。会议通知已 于 2024 年 12 月 25 日以书面、电子邮件等方式向全体董事发出。本次会议应出 席董事 9 人，实际出席董事 9 人。本次会议由董事长胡淇翔主持，部分高管列席 会议。本次会议召开符合《公司法》和《公司章程》的有关规定。 经与会董事审议，本次会议以投票 ...

浙江三美化工股份有限公司 证券代码：603379 证券简称：三美股份 公告编号：2025-002 第六届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三美化工股份有限公司（以下简称"公司"）于 2024 年 12 月 31 日以现 场表决方式在公司会议室召开第六届监事会第十三次会议。会议通知已于 2024 年 12 月 25 日以书面、电子邮件等方式向全体监事发出。本次会议应出席监事 3 人，实际出席监事 3 人。监事会主席陈侃主持会议，董事会秘书列席会议。本次 会议召开符合《公司法》和《公司章程》的有关规定。 经与会监事审议，本次会议以投票表决的方式审议通过了以下议案： 一、审议通过《关于使用闲置自有资金委托理财的议案》。 内容详见 2025 年 1 月 2 日公司在上海证券交易所网站 www.sse.com.cn 以及 2025 年 1 月 3 日在《上海证券报》披露的《浙江三美化工股份有限公司关于使 用闲置自有资金委托理财的公告》。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 ...